These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12679744)

  • 41. Problems in human aggression research.
    de Koning P; Mak M
    J Neuropsychiatry Clin Neurosci; 1991; 3(2):S61-5. PubMed ID: 1821224
    [No Abstract]   [Full Text] [Related]  

  • 42. Drug-induced disinhibition in psychiatrically hospitalized children.
    Carlson GA; Mick E
    J Child Adolesc Psychopharmacol; 2003; 13(2):153-63. PubMed ID: 12880509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychopharmacology in psychodermatology.
    Shukla R; Sasseville D
    J Cutan Med Surg; 2008; 12(6):255-67. PubMed ID: 19317947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reactive and proactive aggression differentially predict later conduct problems.
    Vitaro F; Gendreau PL; Tremblay RE; Oligny P
    J Child Psychol Psychiatry; 1998 Mar; 39(3):377-85. PubMed ID: 9670093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).
    Barzman DH; DelBello MP; Adler CM; Stanford KE; Strakowski SM
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):665-70. PubMed ID: 17201610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder.
    Malone RP; Delaney MA; Luebbert JF; Cater J; Campbell M
    Arch Gen Psychiatry; 2000 Jul; 57(7):649-54. PubMed ID: 10891035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adolescent substance use disorders and comorbidity.
    Simkin DR
    Pediatr Clin North Am; 2002 Apr; 49(2):463-77. PubMed ID: 11993293
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.
    Sobanski E; Banaschewski T; Asherson P; Buitelaar J; Chen W; Franke B; Holtmann M; Krumm B; Sergeant J; Sonuga-Barke E; Stringaris A; Taylor E; Anney R; Ebstein RP; Gill M; Miranda A; Mulas F; Oades RD; Roeyers H; Rothenberger A; Steinhausen HC; Faraone SV
    J Child Psychol Psychiatry; 2010 Aug; 51(8):915-23. PubMed ID: 20132417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trials assessing parmacotherapeutic management of aggression in psychiatric patients: comparability with clinical practice.
    Goedhard LE; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
    Pharmacopsychiatry; 2010 Aug; 43(6):205-9. PubMed ID: 20589596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Divalproex sodium reduces overall aggression in youth at high risk for bipolar disorder.
    Saxena K; Howe M; Simeonova D; Steiner H; Chang K
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):252-9. PubMed ID: 16768633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous-unemotional traits modulate the efficacy of medication?
    Balia C; Carucci S; Coghill D; Zuddas A
    Neurosci Biobehav Rev; 2018 Aug; 91():218-238. PubMed ID: 28137460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder.
    Sinzig J; Döpfner M; Lehmkuhl G; ; Uebel H; Schmeck K; Poustka F; Gerber WD; Günter M; Knölker U; Gehrke M; Hässler F; Resch F; Brünger M; Ose C; Fischer R
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):421-32. PubMed ID: 17822338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Nature and severity of oppositional defiant disorder and conduct disorder as they occur together or separately in children].
    Lapalme M; Déry M
    Can J Psychiatry; 2009 Sep; 54(9):605-13. PubMed ID: 19751549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "Outer-directed irritability": a distinct mood syndrome in explosive youth with a disruptive behavior disorder?
    Donovan SJ; Nunes EV; Stewart JW; Ross D; Quitkin FM; Jensen PS; Klein DF
    J Clin Psychiatry; 2003 Jun; 64(6):698-701. PubMed ID: 12823085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychopharmacologic control of aggression and violence in children and adolescents.
    Calles JL
    Pediatr Clin North Am; 2011 Feb; 58(1):73-84, x. PubMed ID: 21281849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relation of age of onset to the type and severity of child and adolescent conduct problems.
    Lahey BB; Goodman SH; Waldman ID; Bird H; Canino G; Jensen P; Regier D; Leaf PJ; Gordon R; Applegate B
    J Abnorm Child Psychol; 1999 Aug; 27(4):247-60. PubMed ID: 10503644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impulsive aggression, delay discounting, and adolescent suicide attempts: effects of current psychotropic medication use and family history of suicidal behavior.
    Bridge JA; Reynolds B; McBee-Strayer SM; Sheftall AH; Ackerman J; Stevens J; Mendoza K; Campo JV; Brent DA
    J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):114-23. PubMed ID: 25745870
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder.
    Gorman DA; Gardner DM; Murphy AL; Feldman M; Bélanger SA; Steele MM; Boylan K; Cochrane-Brink K; Goldade R; Soper PR; Ustina J; Pringsheim T
    Can J Psychiatry; 2015 Feb; 60(2):62-76. PubMed ID: 25886657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychopharmacology of autism spectrum disorder: evidence and practice.
    Siegel M
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):957-73. PubMed ID: 23040909
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intranasal oxytocin administration promotes emotional contagion and reduces aggression in a mouse model of callousness.
    Zoratto F; Sbriccoli M; Martinelli A; Glennon JC; Macrì S; Laviola G
    Neuropharmacology; 2018 Dec; 143():250-267. PubMed ID: 30213592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.